Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $30,899.84, with a 24-hour trading volume of $91.61B. The asset's market cap is $27.65T, after moving 0.02% in the last day.
Tokenized Eli Lilly And Co is trading at $30,932.66, with a tokenized market cap of $164.81M and a 24-hour trading volume of $82.57M. The tokenized asset has moved 1.19% in the past 24 hours.